Finally, we identified other than PD-1/PD-L1 axis related ICMs in HNSCC, such as HVEM, that are upregulated after RCT and could be envisaged as individual targets in multimodal therapies for HNSCC in the future. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.